Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Leadopharma logo — Pioneering the future of pain, epilepsy, depression, and neu...

Leadopharma

Pioneering the future of pain, epilepsy, depression, and neurodegenerative treatment through innovative drug synthesis and advanced pharmacology research.

Founded 2016 Series A Biotechnology, Pharmaceutical

General Information

Company Name Leadopharma
Founded Year 2016
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Leadopharma. To contact Leadopharma, visit leado-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Leadopharma compare?

A PDF of Leadopharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Leadopharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Leadopharma

Leadopharma, founded in 2016, is a biotechnology and pharmaceutical startup pioneering the future of pain, epilepsy, depression, and neurodegenerative treatment through innovative drug synthesis and advanced pharmacology research. The company has built a comprehensive pharmaceutical chemistry and ion channel drug R&D platform and a team capable of independently conducting drug synthesis, activity screening, and early safety pharmacology research for ion channel targets. In its latest financing round, Leadopharma secured a Series A investment on 07 August 2023 from a consortium of notable investors including Shanghai Healthcare Capital, Zhangke Lingyi Investment, Hongfeng Investment Management, and Hongke Baishi. With its focus on addressing critical unmet medical needs, Leadopharma is poised to make significant strides in the field of pharmaceutical research and development.

Business keywords: pharmaceutical research, drug synthesis, pharmacology, ion channels, neurodegenerative diseases, epilepsy treatment, pain management, depression treatment, R&D platform, safety pharmacology, innovative drugs, pharmaceutical chemistry, activity screening, drug development, ion channel targets

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 4
Shanghai Healthcare Capital
Shanghai Healthcare Capital, Zhangke Lingyi Investment +2
07 Aug 2023
Seed Round Undisclosed -
01 Nov 2022
Seed Round Undisclosed 2
Shanghai Healthcare Capital
Shanghai Healthcare Capital, Hongfeng Investment Management
01 Jul 2021
Angel Round Undisclosed -
01 Jul 2019
Angel Round Undisclosed 1
Zhangkelingyi
01 Apr 2016

Leadopharma Alternatives & Competitors

View All Alternatives
Leadopharma vs
Cavion
Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inhibition

Series A
Biotechnology, Health Care
Leadopharma vs
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. China

Strive to be your first choice of a chemistry service provider based on specialized and innovative s...

Series C
23 employees
Biotechnology, Pharmaceutical
Leadopharma vs
Relmada Therapeutics, Inc
Relmada Therapeutics, Inc United States

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the treatment of...

Post-IPO Equity
32 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Leadopharma

Pioneering the future of pain, epilepsy, depression, and neurodegenerative treatment through innovative drug synthesis and advanced pharmacology research.
Leadopharma was founded in 2016.
Leadopharma operates in Biotechnology and Pharmaceutical. Its work centres on pharmaceutical research, drug synthesis, pharmacology and ion channels.
Leadopharma has completed 5 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to Leadopharma include Cavion, Bellen Chemistry Co., Ltd., Relmada Therapeutics, Inc, Xenon Pharmaceuticals Inc., Cholesgen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leadopharma and Cavion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Leadopharma, https://bouncewatch.com/company/leadopharma, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes